EU food supplement health claims: wording, conditions and marketing use

“Magnesium contributes to a reduction of tiredness and fatigue.”

A product-facing interpretation of the authorised magnesium fatigue claim, separating normal-function language from instant-energy and medical promises.

“Vitamin D contributes to the normal function of the immune system.”

A practical wording map for the authorised vitamin D immune-function claim — including the source condition and where common marketing language starts to overreach.

“Calcium is needed for the maintenance of normal bones.”

A claim-level decision page for calcium and bone maintenance, with a clear boundary between maintaining normal bones and promising stronger bones or disease prevention.

“Creatine increases physical performance in successive bursts of short-term, high intensity exercise.”

A claim-level interpretation of the authorised creatine performance wording, including the 3 g daily intake, adult high-intensity-exercise audience and the boundary to broader strength, energy and endurance promises.

“A combination of artichoke leaf dry extract standardised in caffeoylquinic acids, monacolin K in red yeast rice, sugar-cane derived policosanols, procyanidolic oligomers from French maritime pine bark, garlic dry extract standardised in allicin, d-α-tocopheryl hydrogen succinate, riboflavin and inositol hexanicotinate reduces blood LDL-cholesterol concentrations. High LDL-cholesterol is a risk factor in the development of coronary heart disease.”

An authorised disease-risk-reduction claim whose use remains restricted to the named applicant during the protected-data period. Authorisation alone does not establish that another operator may use it.